BBOT Bridgebio Oncology Therapeutics, Inc.

Fundamentals / CIK 0001869105 / USD

Bridgebio Oncology Therapeutics, Inc. reported $346.2M in total assets and a net loss of $171.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BBOT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$125.3MFY 2023 Net Income: -$42K2023FY 2024 Net Income: -$74.28M2024FY 2025 Net Income: -$134.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $121.2M $73.11M --
Total Operating Expenses $145.8M $80.86M --
Operating Income -$145.8M -$80.86M -$42K
EBITDA -$145.5M -$80.66M --
Interest Income $11.34M $8.45M --
Income Tax Expense $0 $0 --
Net Income -$134.0M -$74.28M -$42K
Basic EPS -$4.30 -$5,756.41 --
Diluted EPS -$4.30 -$5,756.41 --
Basic Shares Outstanding 31.1M 12.9K --
Diluted Shares Outstanding 31.1M 12.9K --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $29.59M $49.23M $39.80M $38.07M $35.05M $27.44M $20.64M --
Total Operating Expenses $37.49M $60.19M $46.18M $43.41M $49.18M $30.09M $23.14M --
Operating Income -$37.49M -$60.19M -$46.18M -$43.41M -$49.18M -$30.09M -$23.14M -$21.88M
EBITDA -$37.39M -$60.09M -$46.10M -$43.32M -$49.08M -$29.99M -$23.08M --
Interest Income $3.26M $3.55M $3.94M $4.42M $3.44M $2.07M $1.99M $2.25M
Income Tax Expense $0 $0 -- $0 $0 $0 $0 --
Net Income -$34.18M -$56.45M -$42.11M -$38.80M -$44.76M -$28.43M -$22.05M -$19.69M
Basic EPS -$0.43 -$705.20 -$526.11 -- -$1.03 -$566.46 -$54.23 --
Diluted EPS -$0.43 -$705.20 -$526.11 -- -$1.03 -$566.46 -$54.23 --
Basic Shares Outstanding 80.2M 80.1M 80.0K -- 43.5M 50.2M 406.7K --
Diluted Shares Outstanding 80.2M 80.1M 80.0K -- 43.5M 50.2M 406.7K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $373.7M $30.85M $0
Short-Term Investments $51.77M $124.8M --
Cash & Short-Term Investments $425.5M $155.6M $0
Total Current Assets $432.4M $158.7M --
Property, Plant & Equipment, Net $956K $490K --
Long-Term Investments $0 -- --
Other Non-Current Assets $12.57M $4.99M --
Total Non-Current Assets $15.98M $5.61M --
Total Assets $448.4M $164.3M $333K
Accounts Payable $1.37M $3.07M --
Total Current Liabilities $35.04M $19.58M $396K
Total Non-Current Liabilities $2.24M $0 $0
Total Liabilities $37.28M $19.58M $396K
Total Debt (incl. Leases) $2.77M -- --
Common Stock $8.0K $0 --
Retained Earnings -$356.6M -$222.5M -$89K
Accumulated Other Comp. Income $16K $348K --
Total Stockholders' Equity $411.1M -$178.6M -$115.6M
Total Equity $411.1M -$178.6M -$115.6M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $76.48M $54.06M $52.66M $373.7M $408.7M $664K $963K $30.85M
Short-Term Investments $117.4M $171.6M $199.6M $51.77M $59.54M -- -- $124.8M
Cash & Short-Term Investments $315.3M $344.1M $388.9M $425.5M $468.3M $664K $963K $155.6M
Total Current Assets $208.3M $242.4M $266.5M $432.4M $476.0M $877K $1.24M $158.7M
Property, Plant & Equipment, Net $815K $878K $938K $956K $827K -- -- $490K
Long-Term Investments $121.5M $118.4M $136.6M $0 -- -- -- --
Other Non-Current Assets $13.50M $12.79M $11.24M $12.57M $5.38M -- -- $4.99M
Total Non-Current Assets $137.9M $134.3M $151.1M $15.98M $8.78M $196.5M $194.4M $5.61M
Total Assets $346.2M $376.7M $417.6M $448.4M $484.8M $197.4M $195.7M $164.3M
Accounts Payable $10.26M $6.73M $12.09M $1.37M $3.65M -- -- $3.07M
Total Current Liabilities $51.03M $51.63M $43.26M $35.04M $35.71M $2.63M $1.87M $19.58M
Total Non-Current Liabilities $1.81M $1.96M $2.11M $2.24M $2.38M $5.52M $5.52M $0
Total Liabilities $52.84M $53.59M $45.37M $37.28M $38.09M $8.15M $7.39M $19.58M
Total Debt (incl. Leases) $2.38M $2.51M $2.64M $2.77M $2.89M -- -- --
Common Stock $8.0K $8.0K $8.0K $8.0K $8.0K -- -- $0
Retained Earnings -$489.3M -$455.1M -$398.7M -$356.6M -$317.8M -$7.27M -$6.15M -$222.5M
Accumulated Other Comp. Income -$1.70M -$959K -$981K $16K $36K -- -- $348K
Total Stockholders' Equity $293.4M $323.1M $372.3M $411.1M $446.7M -$227.7M -$200.0M -$178.6M
Total Equity $293.4M $323.1M $372.3M $411.1M $446.7M -$227.7M -$200.0M -$178.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$134.0M -$74.28M -$42K
Depreciation & Amortization $280K $208K --
Stock-Based Compensation $5.87M $4.42M --
Change in Payables -$1.84M $2.50M --
Operating Cash Flow -$113.9M -$55.03M --
Capital Expenditure -$606K -$49K --
Free Cash Flow -$114.5M -$55.08M --
Purchases of Investments -$83.92M -$154.4M --
Investing Cash Flow $73.33M -$120.5M --
Common Stock Issued $112.3M -- --
Financing Cash Flow $383.4M $206.3M --
Net Change in Cash $342.8M $30.73M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$34.18M -$56.45M -$42.11M -$38.80M -$44.76M -$28.43M -$22.05M -$19.69M
Depreciation & Amortization $100K $100K $74K $84K $100K $100K $54K --
Stock-Based Compensation $4.75M $7.23M $3.87M $2.95M $1.43M $36K $627K $587K
Change in Payables $3.53M -$5.33M $10.69M -$2.42M $2.09M -$2.05M $537K --
Operating Cash Flow -$28.36M -$44.36M -$35.92M -$42.23M -$28.77M -$23.29M -$19.60M -$15.04M
Capital Expenditure -$13K -$47K -$24K -$73K -$140K -$231K -$162K --
Free Cash Flow -$28.38M -$44.41M -$35.94M -$42.31M -$28.91M -$23.52M -$19.76M --
Purchases of Investments -$16.95M -$7.54M -$311.6M -$21.04M -$4.46M -$33.98M -$24.43M --
Investing Cash Flow $50.34M $45.73M -$285.4M $7.77M $40.55M $9.64M $15.37M $25.56M
Common Stock Issued $0 $0 $112.3M -- -- -- -- --
Financing Cash Flow $442K $37K $295K -$586K $365.4M $18.96M -$404K $52K
Net Change in Cash $22.42M $1.41M -$321.0M -$35.05M $377.2M $5.30M -$4.63M $10.57M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -32.6% -- --
Return on Assets (ROA) -29.9% -45.2% -12.5%
Current Ratio 12.34x 8.10x --
Quick Ratio 12.14x 7.95x 0.00x
Debt to Equity 0.01x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -58.5% -56.4% -41.4% -32.6% -25.7% -- -- --
Return on Assets (ROA) -49.5% -48.3% -36.9% -29.9% -23.7% -44.3% -41.3% -45.2%
Current Ratio 4.08x 4.69x 6.16x 12.34x 13.33x 0.33x 0.66x 8.10x
Quick Ratio 6.18x 6.66x 8.99x 12.14x 13.11x 0.25x 0.51x 7.95x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001869105) · from December 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:45 UTC · Open in terminal